The California biotech, which is partnered with Eli Lilly and J&J, plans to use the funds to advance one of its wholly owned drugs for eczema into Phase 1 testing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,